Private Equity

Updated:

Yanghe Biomedicine Industry Fund

Yanghe Biomedicine Industry Fund is a asset manager based in Guangzhou; the Altss profile covers its classification, headquarters, registration, AUM band, and...

Yanghe Biomedicine Industry Fund

Yanghe Biomedicine Industry Fund is a private equity firm based in Guangzhou, China. It focuses on growth investments.

General information

Firm type

Private Equity Firm

Location

Region

Asia

Country

China

City

Guangzhou

Corporate office

Guangzhou, China

Sector focus

Digital HealthHealthcare ServicesAgriTech & FoodTech

Frequently asked questions

What is Yanghe Biomedicine Industry Fund's investment focus?

The fund targets early-stage companies in biomedicine, medical devices, diagnostics and agricultural biotechnology, deploying across seed, start-up and growth stages from its base in Guangzhou. This dual focus on human health and agri-food biotech distinguishes it from pure-play life-science investors in China. No portfolio companies have been publicly disclosed in English-language records.

Who runs investment decisions at Yanghe Biomedicine Industry Fund?

Specific principals and investment committee members have not been identified through public record or English-language media. The fund's ownership structure, corporate affiliations and decision-making hierarchy remain undisclosed outside of China's domestic regulatory or corporate filings. No named investment leads are currently available.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Guangzhou Private Equity Firm profiles